Background: Cardiovascular biomarkers are crucial for monitoring cancer therapy-related cardiac toxicity, but the effects on early stage are still inadequate. To screen biomarkers in patients with breast cancer who receive anthracycline-containing chemotherapy, we studied the behavior of six biomarkers during chemotherapy and their association with chemotherapy-related cardiac toxicity.
Methods: In a prospective cohort of 73 patients treated with anthracycline-containing chemotherapy, soluble suppression of tumorigenicity 2 (sST2), high-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), myoglobin, creatine kinase isoenzyme MB, and heart-fatty acid binding protein were measured at baseline, during chemotherapy cycle (C1-C6). According to whether arrhythmia occurred, patients were divided into two groups (healthy group or arrhythmias group), and basic clinical characteristics were collected and compared. Logistic regression analyses and receiver operating characteristic (ROC) curves were conducted to investigate the association between the changes in biomarkers and arrhythmia.
Results: sST2 levels increased significantly from baseline to C1 (P < 0.01). NT-proBNP levels decreased from baseline to C1 and C5 (P < 0.01). The logistic regression analysis showed a greater risk of arrhythmia was associated with interval changes in sST2 [odds ratio (OR): 1.27; 95% CI: 1.03-1.56; P = 0.024] and NT-proBNP (OR: 0.83; 95% CI: 0.70-0.98; P = 0.029). The ROC curves showed that ΔsST2, ΔNT-proBNP, and ΔsST2 + ΔNT-proBNP had good predictive value for arrhythmia (areas under the curves were 0.631, 0.633, and 0.735, respectively, P < 0.05).
Conclusions: Early changes in sST2 and NT-proBNP levels offer additive information for early arrhythmia prediction in breast cancer patients who receive anthracycline-containing chemotherapy.
背景:心血管生物标志物对于监测癌症治疗相关的心脏毒性至关重要,但在早期的作用仍然不足。为了筛选接受蒽环类药物化疗的乳腺癌患者的生物标志物,我们研究了六种生物标志物在化疗期间的行为及其与化疗相关心脏毒性的关系。方法:对73例接受蒽环类药物化疗的患者进行前瞻性队列研究,在基线和化疗周期(C1-C6)测量可溶性致瘤性抑制2 (sST2)、高敏心肌肌钙蛋白T、n端前b型利钠肽(NT-proBNP)、肌红蛋白、肌酸激酶同型酶MB和心脏脂肪酸结合蛋白。根据是否发生心律失常将患者分为两组(健康组和心律失常组),收集基本临床特征并进行比较。采用Logistic回归分析和受试者工作特征(ROC)曲线探讨生物标志物变化与心律失常之间的关系。结果:sST2水平从基线到C1水平显著升高(P P P = 0.024), NT-proBNP水平显著升高(OR: 0.83;95% ci: 0.70-0.98;p = 0.029)。ROC曲线显示ΔsST2、ΔNT-proBNP和ΔsST2 + ΔNT-proBNP对心律失常有较好的预测价值(曲线下面积分别为0.631、0.633和0.735)。P结论:sST2和NT-proBNP水平的早期变化为蒽蒽类化疗后乳腺癌患者早期心律失常预测提供了附加信息。
{"title":"Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies.","authors":"Cuncun Chen, Hui Zheng, Yanchun Wang, Ying Tong, Heng Zhang, Suhong Xie, Xiaolu Ma, Minglei Jiang, Zhiyun Gong, Tianqing Yan, Yanan Tian, Lin Guo, Renquan Lu","doi":"10.3389/fcvm.2024.1477679","DOIUrl":"10.3389/fcvm.2024.1477679","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular biomarkers are crucial for monitoring cancer therapy-related cardiac toxicity, but the effects on early stage are still inadequate. To screen biomarkers in patients with breast cancer who receive anthracycline-containing chemotherapy, we studied the behavior of six biomarkers during chemotherapy and their association with chemotherapy-related cardiac toxicity.</p><p><strong>Methods: </strong>In a prospective cohort of 73 patients treated with anthracycline-containing chemotherapy, soluble suppression of tumorigenicity 2 (sST2), high-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), myoglobin, creatine kinase isoenzyme MB, and heart-fatty acid binding protein were measured at baseline, during chemotherapy cycle (C1-C6). According to whether arrhythmia occurred, patients were divided into two groups (healthy group or arrhythmias group), and basic clinical characteristics were collected and compared. Logistic regression analyses and receiver operating characteristic (ROC) curves were conducted to investigate the association between the changes in biomarkers and arrhythmia.</p><p><strong>Results: </strong>sST2 levels increased significantly from baseline to C1 (<i>P</i> < 0.01). NT-proBNP levels decreased from baseline to C1 and C5 (<i>P</i> < 0.01). The logistic regression analysis showed a greater risk of arrhythmia was associated with interval changes in sST2 [odds ratio (OR): 1.27; 95% CI: 1.03-1.56; <i>P</i> = 0.024] and NT-proBNP (OR: 0.83; 95% CI: 0.70-0.98; <i>P</i> = 0.029). The ROC curves showed that ΔsST2, ΔNT-proBNP, and ΔsST2 + ΔNT-proBNP had good predictive value for arrhythmia (areas under the curves were 0.631, 0.633, and 0.735, respectively, <i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Early changes in sST2 and NT-proBNP levels offer additive information for early arrhythmia prediction in breast cancer patients who receive anthracycline-containing chemotherapy.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1477679"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-12eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1514103
Yikang Xu, Jingru Ma, Yang Yang, Limin Liu, Xinran Zhao, Yu Wang, Alimu Mijiti, Qiangru Cheng, Jun Ma
Objective: To analyze the risk factors for coronary heart disease (CHD) in patients hospitalized in general hospitals in the Tacheng Prefecture, Xinjiang, and to construct and verify the nomogram prediction model for the risk of CHD.
Methods: From June 2022 to June 2023, 489 CHD patients (CHD group) and 520 non-CHD individuals (control group) in Tacheng, Xinjiang, were retrospectively selected. Using a 7:3 ratio, patients were divided into a training group (706 cases) and a validation group (303 cases). General clinical data were compared, and key variables were screened using logistic regression (AIC). A CHD risk nomogram for Tacheng was constructed. Model performance was assessed using ROC AUC, calibration curves, and DCA.
Results: In the training group, non-Han Chinese (OR = 2.93, 95% CI: 2.0-4.3), male (OR = 1.65, 95% CI: 1.0-2.7), alcohol consumption (OR = 1.82, 95% CI: 1.2-2.9), hyperlipidemia (OR = 2.41, 95% CI: 1.7-3.5), smoking (OR = 1.61, 95% CI: 1.0-2.6), diabetes mellitus (OR = 1.62, 95% CI: 1.1-2.4), stroke (OR = 2.39, 95% CI: 1.6-3.7), older age (OR = 1.08, 95% CI: 1.1-1.2), and larger waist circumference (OR = 1.04, 95% CI: 1.0-1.1) were the risk factors for coronary heart disease (all P < 0.05). The area under the curve (AUC) of the work characteristics of the subjects in the training group and the validation group were 0.80 (95% CI: 0.8-0.8) and 0.82 (95% CI: 0.8-0.9), respectively. The Hosmer-Lemeshow test indicated P = 0.325 for the training group and P = 0.130 for the validation group, with calibration curves closely fitting the ideal curve. The predicted values aligned well with actual values, and decision curve analysis results suggest that the model offers a net clinical benefit.
Conclusion: The CHD risk prediction model developed in this study for general hospitals in Tacheng Prefecture, Xinjiang, demonstrates strong predictive performance and serves as a simple, user-friendly, cost-effective tool for medical personnel to identify high-risk groups for CHD.
{"title":"Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China.","authors":"Yikang Xu, Jingru Ma, Yang Yang, Limin Liu, Xinran Zhao, Yu Wang, Alimu Mijiti, Qiangru Cheng, Jun Ma","doi":"10.3389/fcvm.2024.1514103","DOIUrl":"10.3389/fcvm.2024.1514103","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the risk factors for coronary heart disease (CHD) in patients hospitalized in general hospitals in the Tacheng Prefecture, Xinjiang, and to construct and verify the nomogram prediction model for the risk of CHD.</p><p><strong>Methods: </strong>From June 2022 to June 2023, 489 CHD patients (CHD group) and 520 non-CHD individuals (control group) in Tacheng, Xinjiang, were retrospectively selected. Using a 7:3 ratio, patients were divided into a training group (706 cases) and a validation group (303 cases). General clinical data were compared, and key variables were screened using logistic regression (AIC). A CHD risk nomogram for Tacheng was constructed. Model performance was assessed using ROC AUC, calibration curves, and DCA.</p><p><strong>Results: </strong>In the training group, non-Han Chinese (OR = 2.93, 95% CI: 2.0-4.3), male (OR = 1.65, 95% CI: 1.0-2.7), alcohol consumption (OR = 1.82, 95% CI: 1.2-2.9), hyperlipidemia (OR = 2.41, 95% CI: 1.7-3.5), smoking (OR = 1.61, 95% CI: 1.0-2.6), diabetes mellitus (OR = 1.62, 95% CI: 1.1-2.4), stroke (OR = 2.39, 95% CI: 1.6-3.7), older age (OR = 1.08, 95% CI: 1.1-1.2), and larger waist circumference (OR = 1.04, 95% CI: 1.0-1.1) were the risk factors for coronary heart disease (all <i>P</i> < 0.05). The area under the curve (AUC) of the work characteristics of the subjects in the training group and the validation group were 0.80 (95% CI: 0.8-0.8) and 0.82 (95% CI: 0.8-0.9), respectively. The Hosmer-Lemeshow test indicated <i>P</i> = 0.325 for the training group and <i>P</i> = 0.130 for the validation group, with calibration curves closely fitting the ideal curve. The predicted values aligned well with actual values, and decision curve analysis results suggest that the model offers a net clinical benefit.</p><p><strong>Conclusion: </strong>The CHD risk prediction model developed in this study for general hospitals in Tacheng Prefecture, Xinjiang, demonstrates strong predictive performance and serves as a simple, user-friendly, cost-effective tool for medical personnel to identify high-risk groups for CHD.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1514103"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-12eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1429387
Jianqiao Zhao, Can Guo, Mengyuan Cheng, Jie Li, Yangyang Liu, Huahua Wang, Jianping Shen
Introduction: Patients with acute myocardial infarction (AMI) are at high risk of progressing to heart failure (HF). Recent research has shown that lipid droplet-related genes (LDRGs) play a crucial role in myocardial metabolism following MI, thereby influencing the progression to HF.
Methods: Weighted gene co-expression network analysis (WGCNA) and differential expression gene analysis were used to screen a transcriptome dataset of whole blood cells from AMI patients with (AMI HF, n = 16) and without progression (AMI no-HF, n = 16). Functional enrichment analysis were performed to observe the involved function. Machine learning methods were used to screen the genes related to prognosis. Transcriptional factors (TF) were predicted by using relevant databases. ROC curves were drawn to evaluate the TF-LDRG pair in predicting HF in the validation dataset (n = 16) and the clinical trial (n = 13).
Results: The 235 identified genes were primarily involved in pathways related to fatty acid and energy metabolism. 22 genes were screened out that they were strongly associated with prognosis. 35 corresponding transcription factors were predicted. The TF-LDRG pair, ABHD5-ARID3a, was demonstrated good predictive accuracy.
Discussion: Our findings suggest that ABHD5-ARID3a have significant potential as predictive biomarkers for heart failure post-AMI which also provides a foundation for further exploration into the molecular mechanisms underlying the progression from AMI to HF.
急性心肌梗死(AMI)患者进展为心力衰竭(HF)的风险很高。最近的研究表明,脂滴相关基因(LDRGs)在心肌梗死后的心肌代谢中起着至关重要的作用,从而影响心肌梗死的进展。方法:采用加权基因共表达网络分析(WGCNA)和差异表达基因分析筛选AMI合并(AMI HF, n = 16)和无进展(AMI no-HF, n = 16)患者全血细胞转录组数据集。通过功能富集分析观察所涉及的功能。采用机器学习方法筛选与预后相关的基因。利用相关数据库预测转录因子(TF)。绘制ROC曲线,评估验证数据集(n = 16)和临床试验(n = 13)中TF-LDRG对预测HF的作用。结果:所鉴定的235个基因主要参与脂肪酸和能量代谢相关的途径。筛选出22个与预后密切相关的基因。预测了35个相应的转录因子。TF-LDRG对ABHD5-ARID3a具有良好的预测准确性。讨论:我们的研究结果表明,ABHD5-ARID3a作为AMI后心力衰竭的预测性生物标志物具有重要的潜力,这也为进一步探索AMI向HF进展的分子机制提供了基础。
{"title":"Identification of transcription factor-lipid droplet-related gene biomarkers for the prognosis of post-acute myocardial infarction-induced heart failure.","authors":"Jianqiao Zhao, Can Guo, Mengyuan Cheng, Jie Li, Yangyang Liu, Huahua Wang, Jianping Shen","doi":"10.3389/fcvm.2024.1429387","DOIUrl":"10.3389/fcvm.2024.1429387","url":null,"abstract":"<p><strong>Introduction: </strong>Patients with acute myocardial infarction (AMI) are at high risk of progressing to heart failure (HF). Recent research has shown that lipid droplet-related genes (LDRGs) play a crucial role in myocardial metabolism following MI, thereby influencing the progression to HF.</p><p><strong>Methods: </strong>Weighted gene co-expression network analysis (WGCNA) and differential expression gene analysis were used to screen a transcriptome dataset of whole blood cells from AMI patients with (AMI HF, <i>n</i> = 16) and without progression (AMI no-HF, <i>n</i> = 16). Functional enrichment analysis were performed to observe the involved function. Machine learning methods were used to screen the genes related to prognosis. Transcriptional factors (TF) were predicted by using relevant databases. ROC curves were drawn to evaluate the TF-LDRG pair in predicting HF in the validation dataset (<i>n</i> = 16) and the clinical trial (<i>n</i> = 13).</p><p><strong>Results: </strong>The 235 identified genes were primarily involved in pathways related to fatty acid and energy metabolism. 22 genes were screened out that they were strongly associated with prognosis. 35 corresponding transcription factors were predicted. The TF-LDRG pair, ABHD5-ARID3a, was demonstrated good predictive accuracy.</p><p><strong>Discussion: </strong>Our findings suggest that ABHD5-ARID3a have significant potential as predictive biomarkers for heart failure post-AMI which also provides a foundation for further exploration into the molecular mechanisms underlying the progression from AMI to HF.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1429387"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-12eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1426953
Lanlan Qiu, Bo Wu
Background: Hypertension can damage multiple target organs. The younger the age of onset of hypertension is, the greater the risk of cardiovascular disease (CVD) and cardiovascular death. Chronic kidney disease (CKD) is a complication of hypertension, but few studies have investigated the relationship between the age of onset of hypertension and CKD.
Objective: We investigated the relationship between the age of onset of hypertension and CKD.
Method: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 2007-2018. A total of 30,613 participants were assigned to one of four groups. Group 1, no hypertension (n = 19,516); Group 2, age of onset <35 years (n = 2,180); Group 3, 35≤ age of onset <45 years (n = 2,128); and Group 4, age of onset ≥45 years (n = 6,789). Logistic regression analysis was used to evaluate the relationship between the age of onset of hypertension and CKD.
Results: After adjusting for potential confounders, a younger age at onset of hypertension was associated with a greater risk of developing CKD compared with the absence of hypertension (Group 2 OR: 2.52, 95% CI: 1.53-4.14, P < 0.001; Group 3 OR: 1.59, 95% CI: 1.01-2.51, P = 0.048; Group 4 OR: 1.54, 95% CI: 1.00-2.38, P = 0.050).
Conclusions: There was a strong association between the age of onset of hypertension and CKD. The younger the age of onset of hypertension is, the greater the risk of CKD.
背景:高血压可损害多个靶器官。高血压发病年龄越小,心血管疾病(CVD)和心血管死亡的风险越大。慢性肾脏疾病(CKD)是高血压的并发症,但很少有研究探讨高血压发病年龄与CKD的关系。目的:探讨高血压发病年龄与慢性肾病的关系。方法:我们分析2007-2018年国家健康与营养检查调查(NHANES)的数据。共有30,613名参与者被分为四组。1组,无高血压(n = 19,516);第二组,发病年龄n = 2180);第3组,35≤发病年龄n = 2128);4组发病年龄≥45岁(n = 6789)。采用Logistic回归分析评价高血压发病年龄与慢性肾病的关系。结果:在调整了潜在的混杂因素后,与没有高血压的患者相比,高血压发病年龄越小,发生CKD的风险越大(第二组OR: 2.52, 95% CI: 1.53-4.14, P P = 0.048;第四组OR: 1.54, 95% CI: 1.00-2.38, P = 0.050)。结论:高血压发病年龄与慢性肾病有很强的相关性。高血压发病年龄越小,患慢性肾病的风险越大。
{"title":"The relationship between the age of onset of hypertension and chronic kidney disease: a cross-sectional study of the American population.","authors":"Lanlan Qiu, Bo Wu","doi":"10.3389/fcvm.2024.1426953","DOIUrl":"10.3389/fcvm.2024.1426953","url":null,"abstract":"<p><strong>Background: </strong>Hypertension can damage multiple target organs. The younger the age of onset of hypertension is, the greater the risk of cardiovascular disease (CVD) and cardiovascular death. Chronic kidney disease (CKD) is a complication of hypertension, but few studies have investigated the relationship between the age of onset of hypertension and CKD.</p><p><strong>Objective: </strong>We investigated the relationship between the age of onset of hypertension and CKD.</p><p><strong>Method: </strong>We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 2007-2018. A total of 30,613 participants were assigned to one of four groups. Group 1, no hypertension (<i>n</i> = 19,516); Group 2, age of onset <35 years (<i>n</i> = 2,180); Group 3, 35≤ age of onset <45 years (<i>n</i> = 2,128); and Group 4, age of onset ≥45 years (<i>n</i> = 6,789). Logistic regression analysis was used to evaluate the relationship between the age of onset of hypertension and CKD.</p><p><strong>Results: </strong>After adjusting for potential confounders, a younger age at onset of hypertension was associated with a greater risk of developing CKD compared with the absence of hypertension (Group 2 OR: 2.52, 95% CI: 1.53-4.14, <i>P</i> < 0.001; Group 3 OR: 1.59, 95% CI: 1.01-2.51, <i>P</i> = 0.048; Group 4 OR: 1.54, 95% CI: 1.00-2.38, <i>P</i> = 0.050).</p><p><strong>Conclusions: </strong>There was a strong association between the age of onset of hypertension and CKD. The younger the age of onset of hypertension is, the greater the risk of CKD.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1426953"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-12eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1490498
Lin Shuang Mao, Yi Xuan Wang, Zhi Ming Wu, Feng Hua Ding, Lin Lu, Wei Feng Shen, Yang Dai, Ying Shen
Objective: This study compared the value of different systemic immune-inflammatory markers for evaluating coronary collateralization (CC) in patients with type 2 diabetes mellitus (T2DM) and chronic total occlusion (CTO).
Methods: Systemic immune-inflammation index (SII), systemic inflammation response index (SIRI) and pan-immune-inflammation value (PIV) were calculated at admission in 1409 T2DM patients with CTO. The degree of coronary collaterals was estimated using the Rentrop scoring system and categorized into poor (Rentrop score 0 or 1) or good (Rentrop score 2 or 3) CC. The predictors of poor CC were determined by multivariate regression analysis, and the diagnostic potential of these indexes was analyzed by Receiver Operating Characteristic (ROC) curves.
Results: SII, SIRI and PIV levels increased stepwise across Rentrop score 0-3, with significantly higher levels in patients with poor CC than in those with good CC (P < 0.001). After adjusting for confounders, SII, SIRI and PIV (per tertile) remained independent factors for poor CC. SII predicted poor CC better than SIRI and PIV (AUC: 0.758 vs. 0.680 and 0.698, all P < 0.001). There existed an interaction between blood concentration of HbA1c and SII (P < 0.001), with high SII levels being associated with a greater risk (OR: 5.058 vs. 2.444) and providing a better predictive ability for poor CC (AUC: 0.817 vs. 0.731) in patients with HbA1c < 6.5% compared to those with HbA1c ≥ 6.5%.
Conclusion: Our study shows that elevated SII provides a better prediction for poor CC in T2DM patients with CTO especially at good glycemic control.
目的:比较2型糖尿病(T2DM)和慢性全闭塞(CTO)患者不同全身免疫炎症标志物对冠状动脉侧支(CC)的评价价值。方法:计算1409例T2DM合并CTO患者入院时的全身免疫炎症指数(SII)、全身炎症反应指数(SIRI)和泛免疫炎症值(PIV)。采用Rentrop评分系统评估冠状动脉侧支病变程度,并将其分为不良(Rentrop评分0分或1分)和良好(Rentrop评分2分或3分)CC,通过多因素回归分析确定不良CC的预测因素,并通过受试者工作特征(ROC)曲线分析这些指标的诊断潜力。结果:SII、SIRI和PIV水平在Rentrop评分0-3分期间逐步升高,CC差患者的SII水平明显高于CC好患者(P P P P)。结论:我们的研究表明,SII升高可以更好地预测T2DM合并CTO的CC差患者,尤其是血糖控制良好的患者。
{"title":"Elevated systemic immune-inflammatory index predicts poor coronary collateralization in type 2 diabetic patients with chronic total occlusion.","authors":"Lin Shuang Mao, Yi Xuan Wang, Zhi Ming Wu, Feng Hua Ding, Lin Lu, Wei Feng Shen, Yang Dai, Ying Shen","doi":"10.3389/fcvm.2024.1490498","DOIUrl":"10.3389/fcvm.2024.1490498","url":null,"abstract":"<p><strong>Objective: </strong>This study compared the value of different systemic immune-inflammatory markers for evaluating coronary collateralization (CC) in patients with type 2 diabetes mellitus (T2DM) and chronic total occlusion (CTO).</p><p><strong>Methods: </strong>Systemic immune-inflammation index (SII), systemic inflammation response index (SIRI) and pan-immune-inflammation value (PIV) were calculated at admission in 1409 T2DM patients with CTO. The degree of coronary collaterals was estimated using the Rentrop scoring system and categorized into poor (Rentrop score 0 or 1) or good (Rentrop score 2 or 3) CC. The predictors of poor CC were determined by multivariate regression analysis, and the diagnostic potential of these indexes was analyzed by Receiver Operating Characteristic (ROC) curves.</p><p><strong>Results: </strong>SII, SIRI and PIV levels increased stepwise across Rentrop score 0-3, with significantly higher levels in patients with poor CC than in those with good CC (<i>P</i> < 0.001). After adjusting for confounders, SII, SIRI and PIV (per tertile) remained independent factors for poor CC. SII predicted poor CC better than SIRI and PIV (AUC: 0.758 vs. 0.680 and 0.698, all <i>P</i> < 0.001). There existed an interaction between blood concentration of HbA1c and SII (<i>P</i> < 0.001), with high SII levels being associated with a greater risk (OR: 5.058 vs. 2.444) and providing a better predictive ability for poor CC (AUC: 0.817 vs. 0.731) in patients with HbA1c < 6.5% compared to those with HbA1c ≥ 6.5%.</p><p><strong>Conclusion: </strong>Our study shows that elevated SII provides a better prediction for poor CC in T2DM patients with CTO especially at good glycemic control.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1490498"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-12eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1540284
Klaus Christian Haggenmüller, Barbara Reiner, Renate Maria Oberhoffer, Nils Olson, Jochen Weil, Thorsten Schulz
[This corrects the article DOI: 10.3389/fcvm.2024.1428457.].
[这更正了文章DOI: 10.3389/fcvm.2024.1428457.]。
{"title":"Corrigendum: TUM4Health, a holistic student health promotion program. Screening of cardiovascular risk factors in university students.","authors":"Klaus Christian Haggenmüller, Barbara Reiner, Renate Maria Oberhoffer, Nils Olson, Jochen Weil, Thorsten Schulz","doi":"10.3389/fcvm.2024.1540284","DOIUrl":"10.3389/fcvm.2024.1540284","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fcvm.2024.1428457.].</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1540284"},"PeriodicalIF":2.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-11eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1454302
Hao Zhou, Marta Scatena, Lan N Tu, Cecilia M Giachelli, Vishal Nigam
Introduction: The use of cardiopulmonary bypass (CPB) can induce sterile systemic inflammation that contributes to morbidity and mortality, especially in children. Patients have been found to have increased expression of cytokines and transmigration of leukocytes during and after CPB. Previous work has demonstrated that the supraphysiologic shear stresses existing during CPB are sufficient to induce proinflammatory behavior in non-adherent monocytes. The interactions between shear stimulated monocytes and vascular endothelial cells have not been well studied and have important translational implications. With these studies, we tested the hypothesis that non-physiological shear stress experienced by monocytes during CPB affects the integrity and function of the endothelial monolayer.
Methods: We have used an in vitro CPB model to study the interaction between THP-1 monocyte-like cells and human neonatal dermal microvascular endothelial cells (HNDMVECs). THP-1 cells were sheared in polyvinyl chloride (PVC) tubing at 2.1 Pa, twice of the physiological shear stress, for 2 h. ELISA, adhesion and transmigration assays, qPCR, and RNA silencing were used to assess the interactions between THP-1 cells and HNDMVECs were characterized after co-culture.
Results: We found that sheared THP-1 cells adhered to and transmigrated through the HNDMVEC monolayer more readily than static THP-1 controls. Sheared THP-1 cells disrupted the VE-cadherin and led to the reorganization of cytoskeletal F-actin of HNDMVECs. A higher level of IL-8 was detected in the sheared THP-1 and HNDMVEC co-culture medium compared to the static THP-1 and HNDMVEC medium. Further, treating HNDMVECs with IL-8 resulted in increased adherence of non-sheared THP-1 cells, and upregulation in HNDMVECs of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). Finally, inhibition of HNDMVECs CXCR2/IL-8 receptor with Reparixin and of IL-8 expression with siRNA blocked sheared THP-1 cell adhesion to the endothelial monolayer.
Conclusions: These results suggest that CPB-like sheared monocytes promote IL-8 production followed by increased endothelium permeability, and monocyte adhesion and transmigration. This study revealed a novel mechanism of post-CPB inflammation and will contribute to the development of targeted therapeutics to prevent and repair the damage to neonatal patients.
{"title":"Monocyte adhesion to and transmigration through endothelium following cardiopulmonary bypass shearing is mediated by IL-8 signaling.","authors":"Hao Zhou, Marta Scatena, Lan N Tu, Cecilia M Giachelli, Vishal Nigam","doi":"10.3389/fcvm.2024.1454302","DOIUrl":"10.3389/fcvm.2024.1454302","url":null,"abstract":"<p><strong>Introduction: </strong>The use of cardiopulmonary bypass (CPB) can induce sterile systemic inflammation that contributes to morbidity and mortality, especially in children. Patients have been found to have increased expression of cytokines and transmigration of leukocytes during and after CPB. Previous work has demonstrated that the supraphysiologic shear stresses existing during CPB are sufficient to induce proinflammatory behavior in non-adherent monocytes. The interactions between shear stimulated monocytes and vascular endothelial cells have not been well studied and have important translational implications. With these studies, we tested the hypothesis that non-physiological shear stress experienced by monocytes during CPB affects the integrity and function of the endothelial monolayer.</p><p><strong>Methods: </strong>We have used an <i>in vitro</i> CPB model to study the interaction between THP-1 monocyte-like cells and human neonatal dermal microvascular endothelial cells (HNDMVECs). THP-1 cells were sheared in polyvinyl chloride (PVC) tubing at 2.1 Pa, twice of the physiological shear stress, for 2 h. ELISA, adhesion and transmigration assays, qPCR, and RNA silencing were used to assess the interactions between THP-1 cells and HNDMVECs were characterized after co-culture.</p><p><strong>Results: </strong>We found that sheared THP-1 cells adhered to and transmigrated through the HNDMVEC monolayer more readily than static THP-1 controls. Sheared THP-1 cells disrupted the VE-cadherin and led to the reorganization of cytoskeletal F-actin of HNDMVECs. A higher level of IL-8 was detected in the sheared THP-1 and HNDMVEC co-culture medium compared to the static THP-1 and HNDMVEC medium. Further, treating HNDMVECs with IL-8 resulted in increased adherence of non-sheared THP-1 cells, and upregulation in HNDMVECs of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). Finally, inhibition of HNDMVECs CXCR2/IL-8 receptor with Reparixin and of IL-8 expression with siRNA blocked sheared THP-1 cell adhesion to the endothelial monolayer.</p><p><strong>Conclusions: </strong>These results suggest that CPB-like sheared monocytes promote IL-8 production followed by increased endothelium permeability, and monocyte adhesion and transmigration. This study revealed a novel mechanism of post-CPB inflammation and will contribute to the development of targeted therapeutics to prevent and repair the damage to neonatal patients.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1454302"},"PeriodicalIF":2.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-11eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1501680
Thibault Schaeffer, Pauline Bossers, Doris Kienmoser, Oktay Tutarel, Paul Philipp Heinisch, Masamichi Ono, Julie Cleuziou, Jelena Pabst von Ohain, Jürgen Hörer
Objective: To investigate the long-term impact of cardiac surgery on the quality of life in adults with congenital heart disease (ACHDs).
Methods: Patients who had undergone cardiac surgery for congenital heart disease (CHD) at the age of 18 years or more were recruited in a single-center, cross-sectional study. The enrolled subjects completed online questionnaires to assess patient-reported outcomes: perceived health status and life satisfaction, psychological functioning, health behaviors, and illness perception. Clinical variables were correlated to the score results, and results were compared to representative samples from international and German national surveys of healthy subjects and ACHDs.
Results: We enrolled 196 ACHDs (54% women), including 55% with more than one cardiac surgery during their lifetime. The median age at the survey was 43 years, with a median of 13 years since their last cardiac surgery. The majority of patients reported improved subjective wellbeing after cardiac operation and were in functional New York Heart Association class I or II. The severity of underlying CHD, number of previous cardiac operations, and beta-blocker medication had the most substantial negative effects on illness perception. Measured quality of life and health risk behaviors were within the range of values internationally reported for healthy and CHD subjects, respectively.
Conclusions: ACHD, several years after cardiac surgery, reported a subjective improvement in their wellbeing, a life satisfaction comparable to that of healthy individuals, and low health risk behaviors. Illness perception is strongly correlated with the severity of the underlying CHD.
{"title":"Long-term patient-reported outcomes following congenital heart surgery in adults.","authors":"Thibault Schaeffer, Pauline Bossers, Doris Kienmoser, Oktay Tutarel, Paul Philipp Heinisch, Masamichi Ono, Julie Cleuziou, Jelena Pabst von Ohain, Jürgen Hörer","doi":"10.3389/fcvm.2024.1501680","DOIUrl":"10.3389/fcvm.2024.1501680","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the long-term impact of cardiac surgery on the quality of life in adults with congenital heart disease (ACHDs).</p><p><strong>Methods: </strong>Patients who had undergone cardiac surgery for congenital heart disease (CHD) at the age of 18 years or more were recruited in a single-center, cross-sectional study. The enrolled subjects completed online questionnaires to assess patient-reported outcomes: perceived health status and life satisfaction, psychological functioning, health behaviors, and illness perception. Clinical variables were correlated to the score results, and results were compared to representative samples from international and German national surveys of healthy subjects and ACHDs.</p><p><strong>Results: </strong>We enrolled 196 ACHDs (54% women), including 55% with more than one cardiac surgery during their lifetime. The median age at the survey was 43 years, with a median of 13 years since their last cardiac surgery. The majority of patients reported improved subjective wellbeing after cardiac operation and were in functional New York Heart Association class I or II. The severity of underlying CHD, number of previous cardiac operations, and beta-blocker medication had the most substantial negative effects on illness perception. Measured quality of life and health risk behaviors were within the range of values internationally reported for healthy and CHD subjects, respectively.</p><p><strong>Conclusions: </strong>ACHD, several years after cardiac surgery, reported a subjective improvement in their wellbeing, a life satisfaction comparable to that of healthy individuals, and low health risk behaviors. Illness perception is strongly correlated with the severity of the underlying CHD.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1501680"},"PeriodicalIF":2.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-11eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1471686
Yuehang Yang, Xinyi Liu, Junwei Liu, Jiawei Shi, Huadong Li
Bicuspid aortic valve (BAV), the most common congenital cardiac anomaly, predisposes individuals to aortic stenosis and regurgitation due to valve degeneration. Abnormal hemodynamics, arterial wall characteristics, and genetic factors contribute to ascending aorta dilatation, potentially leading to severe complications like aortic dissection. Presently, the most recent guidelines propose that individuals with BAV requiring valve replacement due to valve dysfunction should undergo simultaneous replacement of the ascending aorta when the diameter of aortic dilatation exceeds 4.5 cm. A 60-year-old female patient previously underwent mechanical aortic valve replacement and ascending aortoplasty at our center due to aortic stenosis and a 4.3 cm diameter ascending aorta. In the sixth postoperative year, she was readmitted due to ascending aorta rupture, resulting in blood entering the right atrium and causing acute right heart failure. We performed repair of the rupture and concomitant ascending aorta replacement to prevent further exacerbation of the patient's condition.
{"title":"Aortic valve replacement in a bicuspid aortic valve patient followed by reoperation for ascending aorta rupture: a case report.","authors":"Yuehang Yang, Xinyi Liu, Junwei Liu, Jiawei Shi, Huadong Li","doi":"10.3389/fcvm.2024.1471686","DOIUrl":"10.3389/fcvm.2024.1471686","url":null,"abstract":"<p><p>Bicuspid aortic valve (BAV), the most common congenital cardiac anomaly, predisposes individuals to aortic stenosis and regurgitation due to valve degeneration. Abnormal hemodynamics, arterial wall characteristics, and genetic factors contribute to ascending aorta dilatation, potentially leading to severe complications like aortic dissection. Presently, the most recent guidelines propose that individuals with BAV requiring valve replacement due to valve dysfunction should undergo simultaneous replacement of the ascending aorta when the diameter of aortic dilatation exceeds 4.5 cm. A 60-year-old female patient previously underwent mechanical aortic valve replacement and ascending aortoplasty at our center due to aortic stenosis and a 4.3 cm diameter ascending aorta. In the sixth postoperative year, she was readmitted due to ascending aorta rupture, resulting in blood entering the right atrium and causing acute right heart failure. We performed repair of the rupture and concomitant ascending aorta replacement to prevent further exacerbation of the patient's condition.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1471686"},"PeriodicalIF":2.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11670325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-11eCollection Date: 2024-01-01DOI: 10.3389/fcvm.2024.1525748
Fu Yining, Yuexin Chen
[This corrects the article DOI: 10.3389/fcvm.2023.1181285.].
[这更正了文章DOI: 10.3389/fcvm.2023.1181285.]。
{"title":"Corrigendum: Operative experience on descending aorta with Takayasu arteritis: a review.","authors":"Fu Yining, Yuexin Chen","doi":"10.3389/fcvm.2024.1525748","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1525748","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fcvm.2023.1181285.].</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1525748"},"PeriodicalIF":2.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142885474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}